Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2019, Article ID 2954373, 4 pages
https://doi.org/10.1155/2019/2954373
Case Report

A Rare Case of Ovarian Serous Borderline Tumor with Brain Metastasis

University of California, Irvine Health System, Department of Pathology, Division of Anatomic Pathology, Orange, CA, USA

Correspondence should be addressed to Di Lu; ude.icu@5dul

Received 17 October 2018; Accepted 13 April 2019; Published 22 May 2019

Academic Editor: Alp Usubutun

Copyright © 2019 Sonia Veran-Taguibao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Fischerova, M. Zikan, P. Dundr, and D. Cibula, “Diagnosis, treatment and follow-up of borderline ovarian tumors,” The Oncologist, vol. 17, no. 12, pp. 1515–1533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Hogg, J. Scurry, S.-N. Kim, M. Friedlander, and N. Hacker, “Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma,” Gynecologic Oncology, vol. 106, no. 1, pp. 44–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Robboy, G. L. Mutter, J. Prat, R. C. Bentley, P. Russell, and M. C. Anderson, Pathology of the Female Reproductive Tract, 2nd edition.
  4. J. F. Leake, J. S. Rader, J. D. Woodruff, and N. B. Rosenshein, “Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential,” Gynecologic Oncology, vol. 42, no. 2, pp. 124–130, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. M. D. Chamberlin, G. H. Eltabbakh, S. L. Mount, and B. J. Leavitt, “Metastatic serous borderline ovarian tumor in an internal mammary lymph node,” Gynecologic Oncology, vol. 82, no. 1, pp. 212–215, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. R. Cohen, D. Suki, J. S. Weinberg et al., “Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome,” Journal of Neuro-Oncology, vol. 66, no. 3, pp. 313–325, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Pietzner, G. Oskay-Oezcelik, K. El Khalfaoui, D. Boehmer, W. Lichtenegger, and J. Sehouli, “Brain metastases from epithelial ovarian cancer: Overview and optimal management,” Anticancer Reseach, vol. 29, no. 7, pp. 2793–2798, 2009. View at Google Scholar · View at Scopus
  8. R. J. Kurman, L. H. Ellenson, and B. M. Ronnett, Blaustein's Pathology of Female Genital Tract, New York, NY, USA, 6th edition edition, 2011.
  9. D. M. Gershenson, “Clinical management potential tumours of low malignancy,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 16, no. 4, pp. 513–527, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. C. G. Hannibal, R. Vang, J. Junge, K. Frederiksen, R. J. Kurman, and S. K. Kjaer, “A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma,” Gynecologic Oncology, vol. 144, no. 1, pp. 174–180, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Prat and M. De Nictolis, “Serous borderline tumours of the ovary. A long term follow up of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion,” The American Journal of Surgical Pathology, vol. 26, no. 9, pp. 1111–1128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. A. W. Kennedy and W. R. Hart, “Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long term follow up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma,” Cancer, vol. 78, no. 2, pp. 278–286, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. J. D. Seidman and R. J. Kurman, “Ovarian serous borderline tumors; a critical review of the literature with emphasis on prognostic indicators,” Human Pathology, vol. 31, no. 5, pp. 539–557, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Ferrero, I. Strada, B. Di Marcoberardino et al., “Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management,” International Journal of Gynecologic Cancer, vol. 22, no. 7, pp. 1158–1162, 2012. View at Publisher · View at Google Scholar
  15. E. G. Silva, C. Tornos, Z. Zhuang, M. I. Merino, and D. M. Gershenson, “Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential,” International Journal of Gynecological Pathology, vol. 17, pp. 1–6, 1998. View at Google Scholar
  16. W. F. Moore, R. C. Bentley, A. Berchuck, and S. J. Robboy, “Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumor of the ovary,” The American Journal of Surgical Pathology, vol. 25, pp. 710–718, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. K. McKenney, B. L. Balzer, and T. A. Longacre, “Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion,” The American Journal of Surgical Pathology, vol. 30, no. 10, pp. 1209–1221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. D. Seidman, F. Khedmati, and A. V. Yemelyanova, “Ovarian low grade serous neoplasm: evaluation of sampling recommendations based on tumors expected to have invasion (those with peritoneal invasive LGSC (invasive implants)),” Modern Pathology, vol. 22, supplement 1, 2009. View at Google Scholar
  19. R. Fauvet, J. Boccara, C. Dufournet, E. David-Montefiore, C. Poncelet, and E. Daraï, “Restaging surgery for women with borderline ovarian tumors: results of a french multicenter study,” Cancer, vol. 100, no. 6, pp. 1145–1151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Zapardiel, P. Rosenberg, M. Peiretti et al., “The role of restaging borderline ovarian tumors: Single institution experience and review of the literature,” Gynecologic Oncology, vol. 119, no. 2, pp. 274–277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Winter III, P. R. Kucera, W. Rodgers et al., “Surgical staging in patients with ovarian tumors of low malignant potential,” Obstetrics & Gynecology, vol. 100, no. 4, pp. 671–676, 2002. View at Publisher · View at Google Scholar
  22. C.-L. Ho, R. J. Kurman, R. Dehari, T.-L. Wang, and I.-M. Shih, “Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors,” Cancer Research, vol. 64, no. 19, pp. 6915–6918, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. T. Tsang, M. T. Deavers, C. C. Sun et al., “KRAS (but not BRAF) mutations in ovarian serous borderline tumor are associated with recurrent low grade serous carcinoma,” The Journal of Pathology, vol. 231, no. 4, pp. 449–456, 2013. View at Publisher · View at Google Scholar